Consolidative and salvage thoracic radiotherapy (TRT) in extensive-stage small-cell lung cancer (ES-SCLC) with first-line chemoimmunotherapy: a retrospective study from a single cancer center

被引：0
|
作者：
Lan, Aihua [1 ,2 ,3 ,4 ]
Dong, Huiling [1 ]
Zheng, Zhiqin [5 ]
Chu, Xiao [1 ,2 ,3 ,4 ]
Zhu, Zhengfei [1 ,2 ,3 ,4 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[3] Shanghai Clin Res Ctr Radiat Oncol, Shanghai, Peoples R China
[4] Shanghai Key Lab Radiat Oncol, Shanghai, Peoples R China
[5] Fudan Univ, Shanghai Canc Ctr, Minhang Branch Hosp, Dept Radiat Oncol, Shanghai, Peoples R China
来源：
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2025年 / 55卷
关键词：
Extensive-stage small-cell lung cancer; Immunotherapy; Survival; Thoracic radiotherapy;
D O I：
10.1016/j.lanwpc.2024.101373
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Consolidative thoracic radiotherapy of extensive-stage small cell lung cancer in the era of chemoimmunotherapy: A retrospective analysis concerning patients from southern Italy
    Longo, V.
    Vitiello, F.
    Spinnato, F.
    Ambrosio, F.
    Del Giudice, T.
    Sergi, M. C. I.
    Casaluce, F.
    Montrone, M.
    Gilli, M.
    Reale, M. L.
    Di Liello, R.
    Russo, A.
    Sforza, V.
    Gristina, V.
    Servetto, A.
    Cristofano, A.
    Viscardi, G.
    Marchese, A.
    Galetta, D.
    Della Corte, C. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1067 - S1067
  • [12] Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as fi rst-line therapy for extensive-stage small-cell - cell lung cancer (ES-SCLC): a phase II trial
    Chen, Dawei
    Zou, Bing
    Li, Butuo
    Gao, Aiqin
    Huang, Wei
    Shao, Qian
    Meng, Xiangjiao
    Zhang, Pinliang
    Tang, Xiaoyong
    Hu, Xudong
    Zhang, Yan
    Guo, Jun
    Zhao, Changhong
    Yuan, Jiajia
    Li, Qian
    Zhu, Changbin
    Yu, Jinming
    Wang, Linlin
    ECLINICALMEDICINE, 2024, 75
  • [13] Anlotinib plus etoposide and cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): a single-arm, phase II study
    Kong, Tiandong
    Chen, Lu
    Zhao, Xiaoli
    Duan, Fangfang
    Zhou, Hanli
    Wang, Lei
    Liu, Danna
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (05) : 1095 - 1105
  • [14] Anlotinib plus etoposide and cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): a single-arm, phase II study
    Tiandong Kong
    Lu Chen
    Xiaoli Zhao
    Fangfang Duan
    Hanli Zhou
    Lei Wang
    Danna Liu
    Investigational New Drugs, 2022, 40 : 1095 - 1105
  • [15] Real world outcomes in extensive stage small cell lung cancer (ES-SCLC) treated with consolidative thoracic radiation (cTRT) and chemoimmunotherapy (CIT): A population level study.
    Gibson, Amanda Williams
    Dean, Michelle Liane
    Kerba, Marc
    Navani, Vishal
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [16] Trilaciclib (T) decreases myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy plus atezolizumab
    Daniel, D.
    Kuchava, V.
    Bondarenko, I.
    Ivashchuk, O.
    Spigel, D.
    Dasgupta, A.
    Reddy, S.
    Melkadze, T.
    Jaal, J.
    Kudaba, I.
    Hart, L.
    Matitashvili, A.
    Koynov, K. D.
    Yang, Z.
    Wolfe, S. G.
    Malik, R.
    Morris, S. R.
    Antal, J. M.
    Goldschmidt, J.
    ANNALS OF ONCOLOGY, 2019, 30 : 713 - 713
  • [17] Chemoimmunotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer and ECOG Performance Status of 2 or 3
    Agarwal, M.
    Liu, A.
    Langlais, B.
    Leventakos, K.
    Yu, N. Y.
    Almquist, D.
    Manochakian, R.
    Ernani, V.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S543 - S543
  • [18] Chemoimmunotherapy combined with consolidative thoracic radiotherapy for extensive-stage small cell lung cancer: A systematic review and meta-analysis
    Feng, Baijie
    Zheng, Yue
    Zhang, Jiayuan
    Tang, Min
    Na, Feifei
    RADIOTHERAPY AND ONCOLOGY, 2024, 190
  • [19] First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
    Horn, L.
    Mansfield, A. S.
    Szczesna, A.
    Havel, L.
    Krzakowski, M.
    Hochmair, M. J.
    Huemer, F.
    Losonczy, G.
    Johnson, M. L.
    Nishio, M.
    Reck, M.
    Mok, T.
    Lam, S.
    Shames, D. S.
    Liu, J.
    Ding, B.
    Lopez-Chavez, A.
    Kabbinavar, F.
    Lin, W.
    Sandler, A.
    Liu, S. V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (23): : 2220 - 2229
  • [20] Paraneoplastic acquired haemophilia A in extensive-stage small cell lung cancer (ES-SCLC) in the era of immunotherapy
    Pauls, Mehrnoosh
    Rydz, Natalia
    Nixon, Nancy A.
    Ezeife, Doreen
    BMJ CASE REPORTS, 2021, 14 (01)
12345